DRUG VAZOMIRIN IN THE THERAPY OF CENTRAL DIABETES INSIPIDUS IN CHILDREN


N.A. Mazerkina

FSBI SRI of Neurosurgery n.a. Acad. N.N. Burdenko, Moscow
The article considers the etiopathogenesis and principles of diagnosis of central diabetes insipidus (CDI); the features of disease in neurosurgical practice are discussed. In particular, the practicability of the use of intranasal dosage form of desmopressin (Vazomirin) in the treatment of such patients is justified. Clinical example of the successful use of this drug by patient 4.5 years old with CDI after removal of intraextraventricular craniopharyngioma is presented. It is emphasized that the Vazomirin is effective drug in the therapy of CDI in neurosurgical practice, does not cause significant side effects and can be used in pediatric practice.

About the Autors


N.A.Mazerkina – MD (endocrinologist at the 1st Department of the SRINS n.a. N.N. Burdenko, Address: 125047, Moscow, 4th Tverskaya-Yamskaya street, bild.16. Office.tel. 8-499-250-8522, mobile tel. 8-916-329-5271, e-mail: nmazer@nsi.ru


Similar Articles


Бионика Медиа